ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

GENE Genetic Technologies Ltd

2.18
0.00 (0.00%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Genetic Technologies Ltd GENE 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 2.18 07:20:53
개장가 저가 고가 종가 전일 종가
2.21 2.1552 2.269 2.221 2.18
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
23/04/202404:00GLOBEGenetic Technologies Announces Closing of US$2 Million..
19/04/202401:17GLOBEGenetic Technologies Announces $2 Million Registered Direct..
17/04/202421:00GLOBENew Precision Oncology Tests to Drive Personalised Therapies..
16/04/202421:00GLOBEGeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year..
11/04/202421:00GLOBEGTG to pilot GeneType in Breast Screen centers across the..
08/04/202421:00GLOBEEVENT - Empowering Women Through Knowledge; Humanise Health..
02/04/202421:05GLOBEGenetic Technologies’ Digital Strategy Ignites Significant..
26/03/202421:00GLOBEGTG Global Collaborations and Innovation Update
25/03/202421:00GLOBEGENE to develop Worlds Most Advanced Comprehensive Risk Test..
26/02/202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/02/202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/02/202404:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/01/202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/01/202422:00GLOBELaunching our most comprehensive test and expanding into new..
09/01/202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/01/202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/01/202422:00GLOBEGenetic Technologies Regains Compliance with Nasdaq Minimum..
05/01/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
28/12/202322:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/12/202322:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/12/202307:00EDGAR2Form F-3 - Registration statement by foreign private issuers
14/12/202322:00GLOBEGeneType's Groundbreaking Saliva Test Transforms Early..
12/12/202322:00GLOBEGenetic Technologies Limited Announces Ordinary Share..
30/10/202321:00GLOBEGene Business Update: Private Hospital Partnership; Expanded..
18/10/202321:30GLOBEGeneType Predicting Risk of Pancreatic Cancer: Major..
27/09/202322:00GLOBEGTG Signs Precision Medicine Pilot with Australia’s Largest..
12/09/202321:00GLOBEBreakthrough: GeneType for Pancreatic Cancer, Melanoma, and..
11/09/202321:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/09/202321:30GLOBEGENE Positioned at the Forefront of Multi-cancer Clinical..
11/09/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/09/202323:00GLOBEGenetic Technologies Limited and 60 Degrees Pharmaceuticals..
30/08/202321:45GLOBEAnnual Results – Momentum Building on our Commercial Plans
09/08/202321:00GLOBEGenetic Technologies Limited Announces Updated Investor..
28/07/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/07/202321:00GLOBEQuarterly Activities Update: Encouraging Growth for geneType..
21/07/202321:00GLOBEGenetic Technologies Receives Nasdaq Notification Regarding..
23/05/202321:00GLOBEGeneType featured on U.S. National TV to raise Breast Cancer..

최근 히스토리

Delayed Upgrade Clock